How should I treat a 16‑year‑old adolescent with CIBA (chronic illness) who has depression and death‑related anxiety?

Treatment of a 16-Year-Old with Depression and Death-Related Anxiety

Immediate Safety Assessment and Risk Stratification

You must directly ask about suicidal ideation using specific questions: "Are you thinking about killing yourself?" followed by "Do you have a plan?" and "Do you have access to means such as firearms or medications?" 1 Safety takes absolute precedence over confidentiality in this situation. 2

High-Risk Features Requiring Immediate Psychiatric Hospitalization

Hospitalize immediately if any of the following are present: 1, 3, 4

• Active suicidal ideation with a specific plan and declared intent
• Recent suicide attempt of any medical severity (intent matters more than lethality)
• Persistent desire to die despite intervention
• Severe hopelessness combined with agitation, psychotic symptoms, or substance intoxication
• Poor impulse control or inability to engage in safety planning
• Psychotic features, especially command hallucinations
• Family unable or unwilling to provide 24/7 supervision
• History of prior suicide attempts (strongest predictor of future attempts)

For hospitalization, call 911 if the patient refuses voluntary transport, has severe agitation, or lacks adequate support for safe transport to the emergency department. 4 Maintain continuous 1:1 observation while the patient remains in your office and remove all potential means of harm from the examination room. 4

Lower-Risk Features Allowing Outpatient Management

Outpatient care may be appropriate only when: 1, 4

• Suicidal thoughts are present but without specific plan or immediate intent
• Family is reactive, supportive, and capable of providing continuous supervision
• Patient can form a therapeutic alliance and engage in safety planning
• A same-day mental health evaluation can be arranged (not a delayed appointment)
• No psychotic symptoms, severe agitation, or substance intoxication

Mandatory Environmental Safety Interventions

Instruct parents to remove ALL firearms from the home immediately—physically relocate them to a secure off-site location such as a relative's home or law enforcement storage. 1, 3, 4 Adolescents can often access locked firearms despite parental assumptions, and firearm presence doubles youth suicide risk. 3, 4

Secure all medications (prescription and over-the-counter) in a locked cabinet accessible only to parents. 1, 3, 4 Medication ingestion is the most common method of adolescent suicide attempts. 3

Restrict access to alcohol, illicit substances, knives, and other potential means of self-harm. 1, 3, 4 Implement these restrictions regardless of the patient's current expressed intent, because most adolescent suicide attempts occur within minutes of the decision to act. 3

Safety Planning (Not Contracts)

Do NOT use a "no-suicide contract"—these have no proven efficacy in preventing suicide, provide false reassurance, and may damage the therapeutic alliance. 1, 3, 4

Instead, develop a written, collaborative safety plan with the adolescent that includes: 3, 4

• Personal warning signs of escalating distress
• Internal coping strategies (e.g., breathing exercises, journaling)
• Healthy distraction activities
• Trusted contacts (friends, family members, school counselor)
• Professional crisis resources (988 Suicide & Crisis Lifeline, local emergency department)
• Verification that means restriction has been implemented

A structured written safety plan reduces suicidal behavior by 43% over 12 months. 3

Diagnostic Confirmation and Assessment

Use the Patient Health Questionnaire-9 (PHQ-9) as a screening tool (sensitivity 89.5%, specificity 77.5% at cutoff ≥11), but follow with a direct clinical interview using DSM-5 criteria to confirm the diagnosis. 2 Screening alone does not establish diagnosis. 1, 2

Conduct a confidential interview with the adolescent, explaining that confidentiality will be broken only for imminent danger to self or others. 4, 2

Assess for psychiatric comorbidities that markedly increase suicide risk: 1, 4

• Bipolar disorder (especially mixed states with irritability and impulsivity)
• Psychotic symptoms
• Substance use disorders
• Anxiety disorders
• Eating disorders

Gather collateral information from parents or guardians to reconcile discrepant information and arrive at an accurate diagnosis. 1 Teenagers should be encouraged to allow parental involvement, and the importance of including parents should be emphasized. 1

Treatment Algorithm

First-Line Treatment for Mild-to-Moderate Depression

Initiate evidence-based psychotherapy as first-line treatment, with cognitive-behavioral therapy (CBT) being the most strongly supported modality. 1, 3, 2 CBT is as effective as medication for major depression and reduces post-treatment suicide attempts by approximately 50% in adolescents. 4, 2

Alternative evidence-based psychotherapies include: 3, 2

• Interpersonal therapy for adolescents (IPT-A)
• Dialectical behavior therapy (DBT)—particularly effective for high-risk youth with self-harm behaviors
• Behavioral activation
• Problem-solving therapy

Refer to a psychologist or psychiatrist for diagnostic evaluation and treatment initiation. 2

Treatment for Moderate-to-Severe Depression

For moderate-to-severe symptoms, refer immediately to psychology and/or psychiatry for combination treatment with both psychotherapy and SSRI medication. 2

If pharmacotherapy is indicated, escitalopram is FDA-approved for adolescent major depressive disorder at doses of 10–20 mg daily. 5 The initial dose should be 10 mg daily, as this is the minimum effective dose; 5 mg is sub-therapeutic. 3, 5

Critical SSRI Safety Monitoring (Black-Box Warning)

Schedule weekly in-person or telehealth visits for the first 4 weeks after starting or increasing an SSRI, as the early treatment period carries the highest risk for treatment-emergent suicidal ideation. 3, 5

At each visit, directly ask about new or worsening suicidal thoughts, agitation, restlessness, irritability, insomnia, or unusual behavioral changes. 3, 5

Educate the patient and family to report immediately any worsening depression, new suicidal thoughts, severe agitation, or behavioral changes. 3, 5

Treatment-emergent suicidal ideation occurs in approximately 4% of adolescents on antidepressants versus 2% on placebo, with no completed suicides reported in clinical trials. 3, 5 However, untreated depression itself is a major suicide risk, and the benefits of appropriately dosed antidepressant therapy outweigh the modest increase in ideation risk when vigilant monitoring is in place. 3, 5

Consider changing the therapeutic regimen, including possibly discontinuing the SSRI, in patients whose depression is persistently worse or who are experiencing emergent suicidal thoughts or behaviors. 5

Psychoeducation and Family Involvement

Provide developmentally appropriate psychoeducation to both patient and family about depression causes, symptoms, impairments, and expected treatment outcomes. 2 Discuss limits of confidentiality explicitly. 2

Emphasize that depression is a chronic disease with high recurrence risk, and that treatment should continue for at least 6–12 months after symptom remission to prevent relapse. 2, 6

Follow-Up Schedule

Follow up within 48–72 hours of treatment initiation, then weekly for the first month, then biweekly or monthly until symptoms remit. 2

Maintain ongoing contact with the patient even after referral to mental health specialists, as collaborative care between primary care and mental health providers results in greater reductions in depressive symptoms. 3, 4, 2

School Coordination

Establish partnerships with school personnel to monitor functioning in academic settings. 2 Consider a 504 plan or IEP evaluation if depression significantly impacts academic performance. 2

Common Pitfalls to Avoid

Do not underestimate risk based on low medical lethality of a prior self-harm method—intent matters more than actual lethality. 1, 4 A patient who ingests a non-lethal dose may still have lethal intent and could seek more dangerous means later. 4

Do not accept family reassurance alone when high-risk features are present—families often underestimate risk and overestimate their supervision ability. 4

Do not prescribe tricyclic antidepressants—they carry a high risk of lethal overdose and lack evidence of efficacy in adolescents. 1, 7

Do not prescribe benzodiazepines for anxiety or insomnia—they may increase disinhibition and impulsivity in suicidal adolescents. 1

Do not discontinue an SSRI prematurely based on lack of response at 2 weeks—early discontinuation can worsen depression. 3

Do not rely on the patient's denial of suicidal thoughts as reassurance—absence of reported ideation does not guarantee safety when underlying stressors persist. 3, 4

Documentation Requirements

Record the specific nature of current suicidal thoughts (passive vs. active), presence or absence of a plan/intent, and any changes since prior visits. 3, 4

Document the mental status examination, including mood, affect, psychomotor activity, and thought content. 3, 4

Note the family's capacity to provide supervision and their understanding of warning signs. 3, 4

Record means-restriction counseling provided (firearms, medications, sharps). 3, 4

Document the rationale for choosing outpatient management versus hospitalization and the confirmed follow-up appointment date/time. 3, 4